Processes and Intermediates for Preparing a Macrocyclic Protease Inhibitor of HCV
Abstract
A process for preparing [(1R,2R)-4-oxo-1,2-cyclopentanedicarboxylic acid II, by the resolution of racemic 4-oxo-1,2-cyclopentanedicarboxylic acid (V), said process comprising: (a) reacting 4-oxo-1,2-cyclopentanedicarboxylic acid (V) with brucine or (1R,2S)-(−)-ephedrine, thus preparing the bis-brucine or bis-(1R,2S)-(−)-ephedrine salt of (V), and (b) precipitating selectively the bis-brucine or bis-(1R,2S)-(−)-ephedrine salt of (1R,2R)-4-oxo-1,2-cyclopentanedicarboxylic acid II, while the bis-brucine or bis-(1R,2S)-(−)-ephedrine salt of [(1S,2S)-4-oxo-1,2-cyclopentanedicarboxylic acid stays in solution; (c) liberating the acid II by removal of brucine or (1R,2S)-(−)-ephedrine from the precipitated salt obtained in step (b).
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . (canceled)
3 . (canceled)
4 . The [(1R,2R)-4-oxo-1,2-cyclopentanedicarboxylic acid salt with brucine (1:2), having the structure III.
5 . The [(1R,2R)-4-oxo-1,2-cyclopentanedicarboxylic acid salt with (1R,2S)-(−)-ephedrine (1:2), having the structure IV.
6 . (canceled)
7 . (canceled)
8 . (canceled)
9 . (canceled)
10 . A compound of formula X:
wherein Bn is benzyl.
11 . A compound of formula XI:
wherein Bn is benzyl and Quin is as defined in claim 8 .
12 . A compound of formula XII:
wherein Quin is as defined in claim 8 .
13 . A compound of formula XIII:
wherein Quin is as defined in claim 8 .
14 . A compound of formula XIV:
wherein Quin is as defined in claim 8 .
15 . A compound of formula XIX:
wherein R 2 is hydrogen, C 1-4 alkyl, aryl, halogen, —SO 2 —C 1-4 alkyl, CN, or NO 2 .
16 . A compound of formula XX:
wherein R 2 is hydrogen, C 1-4 alkyl, aryl, halogen, —SO 2 —C 1-4 alkyl, CN, or NO 2 .
17 . A compound of formula XXI:
wherein R 2 is hydrogen, C 1-4 alkyl, aryl, halogen, —SO 2 —C 1-4 alkyl, CN, or NO 2 .
18 . The compound of claim 15 , 16 or 17 , wherein in the compound of formula XIX, respectively XX or XXI, R 2 is 4-NO 2 .Join the waitlist — get patent alerts
Track US2017152253A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.